• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用诊断时的常规血液参数预测炎症性肠病的并发症

Prediction of complications in inflammatory bowel disease using routine blood parameters at diagnosis.

作者信息

Li Tong, Qian Yuting, Bai Tingting, Li Juanjuan

机构信息

Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China.

Department of Gastroenterology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Ann Transl Med. 2022 Feb;10(4):185. doi: 10.21037/atm-22-123.

DOI:10.21037/atm-22-123
PMID:35280403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8908155/
Abstract

BACKGROUND

Patients with inflammatory bowel disease (IBD) can develop a series of complications over time, including fistulas and perforation, strictures and pseudopolyp formation. Whether there are some effective and economical routine inspection indicators for the early prediction and prevention of complications has clinical significance and is worth exploring.

METHODS

A total of 592 newly diagnosed IBD patients [153 with ulcerative colitis (UC), 439 with Crohn's disease (CD)] were enrolled in a retrospective study. We compared the baseline characteristics (age at diagnosis, sex, clinical disease location and stage), serum C-reactive protein (CRP) level, serum erythrocyte sedimentation rate (ESR) level, total white blood cell (WBC), eosinophil (EOS) and platelet (PLT) counts for all IBD patients. And we evaluated the correlation between these routine parameters and the occurrence of clinical complications (including fistula, perforation, stricture, pseudopolyps or cancerous changes) in the course of IBD by univariate and multivariate analyses. Moreover, we constructed a dual parameter prediction system for complication's verification.

RESULTS

We demonstrated that higher serum CRP levels and total WBC counts independently indicated a higher hazard for the earlier occurrence of pseudopolyp formation in UC patients. Likewise, higher serum ESR and lower eosinophil count predicted the development of fistulas in CD patients, and higher serum ESR and PLT counts accounted for CD patients' strictures.

CONCLUSIONS

Novel predictive models including CRP level, ESR, WBC count, PLT and eosinophils were structured to predict complications in IBD, which might enable more aggressive treatment for patients at risk.

摘要

背景

炎症性肠病(IBD)患者随着时间推移会出现一系列并发症,包括瘘管和穿孔、狭窄以及假息肉形成。是否存在一些有效且经济的常规检查指标用于早期预测和预防并发症具有临床意义,值得探索。

方法

一项回顾性研究纳入了592例新诊断的IBD患者[153例溃疡性结肠炎(UC)患者,439例克罗恩病(CD)患者]。我们比较了所有IBD患者的基线特征(诊断时年龄、性别、临床疾病部位和分期)、血清C反应蛋白(CRP)水平、血清红细胞沉降率(ESR)水平、白细胞(WBC)总数、嗜酸性粒细胞(EOS)和血小板(PLT)计数。通过单因素和多因素分析,我们评估了这些常规参数与IBD病程中临床并发症(包括瘘管、穿孔、狭窄、假息肉或癌变)发生之间的相关性。此外,我们构建了一个双参数预测系统来验证并发症。

结果

我们证明,较高的血清CRP水平和白细胞总数独立表明UC患者较早出现假息肉形成的风险较高。同样,较高的血清ESR水平和较低的嗜酸性粒细胞计数预测了CD患者瘘管的发生,较高的血清ESR水平和PLT计数是CD患者出现狭窄的原因。

结论

构建了包括CRP水平、ESR、白细胞计数、PLT和嗜酸性粒细胞在内的新型预测模型来预测IBD中的并发症,这可能使对有风险的患者进行更积极的治疗成为可能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8489/8908155/afe2c4285654/atm-10-04-185-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8489/8908155/d84cfcfec401/atm-10-04-185-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8489/8908155/805fce6cb9d6/atm-10-04-185-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8489/8908155/79da2cf34690/atm-10-04-185-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8489/8908155/afe2c4285654/atm-10-04-185-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8489/8908155/d84cfcfec401/atm-10-04-185-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8489/8908155/805fce6cb9d6/atm-10-04-185-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8489/8908155/79da2cf34690/atm-10-04-185-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8489/8908155/afe2c4285654/atm-10-04-185-f4.jpg

相似文献

1
Prediction of complications in inflammatory bowel disease using routine blood parameters at diagnosis.利用诊断时的常规血液参数预测炎症性肠病的并发症
Ann Transl Med. 2022 Feb;10(4):185. doi: 10.21037/atm-22-123.
2
Predictive value of serum markers for mucosal healing in patients with inflammatory bowel disease.血清标志物对炎症性肠病患者黏膜愈合的预测价值。
Am J Transl Res. 2024 Aug 15;16(8):3723-3732. doi: 10.62347/LXBG8588. eCollection 2024.
3
Laboratory values in Japanese children with newly diagnosed inflammatory bowel disease.新诊断的日本儿童炎症性肠病的实验室检查值
Pediatr Int. 2019 Jul;61(7):720-725. doi: 10.1111/ped.13892.
4
Adenosine Deaminase as a Useful Biomarker for Diagnosis and Monitoring of Inflammatory Bowel Disease.腺苷脱氨酶作为炎症性肠病诊断和监测的有用生物标志物。
Clin Lab. 2020 Jul 1;66(7). doi: 10.7754/Clin.Lab.2019.191124.
5
Serum α1-Antitrypsin Levels as a Marker of Activity in Pediatric Inflammatory Bowel Disease.血清 α1-抗胰蛋白酶水平作为儿童炎症性肠病活动的标志物。
Inflamm Bowel Dis. 1996 Fall;2(3):168-72.
6
Red cell distribution width for assessment of activity of inflammatory bowel disease.用于评估炎症性肠病活动度的红细胞分布宽度
Dig Dis Sci. 2009 Apr;54(4):842-7. doi: 10.1007/s10620-008-0436-2. Epub 2008 Aug 21.
7
The Relationship between C-Reactive Protein/Albumin Ratio and Disease Activity in Patients with Inflammatory Bowel Disease.炎症性肠病患者C反应蛋白/白蛋白比值与疾病活动度的关系
Gastroenterol Res Pract. 2020 Jun 22;2020:3467419. doi: 10.1155/2020/3467419. eCollection 2020.
8
[Inflammatory bowel disease in children--an analysis of the clinical symptoms and selected biochemical parameters].[儿童炎症性肠病——临床症状及部分生化指标分析]
Med Wieku Rozwoj. 2007 Oct-Dec;11(4):401-7.
9
Analysis of risk factors for early clinical recurrence of inflammatory bowel disease after fecal microbiota transplantation.粪便微生物群移植后炎症性肠病早期临床复发的危险因素分析。
Am J Transl Res. 2021 Nov 15;13(11):12875-12886. eCollection 2021.
10
Prediction of acute pancreatitis complications using routine blood parameters during early admission.利用入院早期的常规血液参数预测急性胰腺炎并发症。
Immun Inflamm Dis. 2022 Dec;10(12):e747. doi: 10.1002/iid3.747.

引用本文的文献

1
Development and validation of a novel model based on clinical characteristics to predict natural disease course progression in patients with stricturing Crohn's disease.基于临床特征的新型模型的开发与验证,用于预测狭窄型克罗恩病患者的自然病程进展
Therap Adv Gastroenterol. 2025 Jul 28;18:17562848251358705. doi: 10.1177/17562848251358705. eCollection 2025.
2
Diagnostic value of lymphocyte-to-monocyte ratio in Crohn's disease: a cross-sectional study.淋巴细胞与单核细胞比值在克罗恩病中的诊断价值:一项横断面研究
Ann Med Surg (Lond). 2025 Feb 7;87(5):2608-2614. doi: 10.1097/MS9.0000000000003017. eCollection 2025 May.
3

本文引用的文献

1
Similar Inhibition of Dynamic Adhesion of Lymphocytes From IBD Patients to MAdCAM-1 by Vedolizumab and Etrolizumab-s.维得利珠单抗和埃妥珠单抗对炎症性肠病患者淋巴细胞与黏膜地址素细胞黏附分子-1动态黏附的抑制作用相似。
Inflamm Bowel Dis. 2018 May 18;24(6):1237-1250. doi: 10.1093/ibd/izy077.
2
Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases.饮食在炎症性肠病发病机制和治疗中的作用演变。
Gut. 2018 Sep;67(9):1726-1738. doi: 10.1136/gutjnl-2017-315866. Epub 2018 May 18.
3
Anti-integrin therapy for inflammatory bowel disease.
Machine learning for temporary stoma after intestinal resection in surgical decision-making of Crohn's disease.
用于克罗恩病手术决策中肠切除术后临时造口的机器学习
BMC Gastroenterol. 2025 Feb 25;25(1):117. doi: 10.1186/s12876-025-03668-7.
4
Predictors of Unplanned Health Care Utilization Among Children with Inflammatory Bowel Disease in a Rural Region of the Southeastern US.美国东南部农村地区炎症性肠病儿童计划性医疗利用率的预测因素。
Dig Dis Sci. 2024 Dec;69(12):4347-4354. doi: 10.1007/s10620-024-08619-y. Epub 2024 Sep 3.
5
Precision Medicine in Inflammatory Bowel Disease: A Spotlight on Emerging Molecular Biomarkers.炎症性肠病中的精准医学:聚焦新兴分子生物标志物
Biomedicines. 2024 Jul 8;12(7):1520. doi: 10.3390/biomedicines12071520.
6
Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options.炎症性肠病:分子基础、预测生物标志物、诊断方法和治疗选择的综合分析。
Int J Mol Sci. 2024 Jun 27;25(13):7062. doi: 10.3390/ijms25137062.
7
The Diagnosis of Intestinal Fibrosis in Crohn's Disease-Present and Future.克罗恩病肠纤维化的诊断——现状与未来。
Int J Mol Sci. 2024 Jun 25;25(13):6935. doi: 10.3390/ijms25136935.
8
Current Approach to Risk Factors and Biomarkers of Intestinal Fibrosis in Inflammatory Bowel Disease.当前炎症性肠病中肠道纤维化的危险因素和生物标志物的处理方法。
Medicina (Kaunas). 2024 Feb 10;60(2):305. doi: 10.3390/medicina60020305.
9
Platelet/Albumin ratio and plateletcrit levels are potential new biomarkers for assessing endoscopic inflammatory bowel disease severity.血小板/白蛋白比值和血小板比容水平可能是评估内镜下炎症性肠病严重程度的新的潜在生物标志物。
BMC Gastroenterol. 2023 Nov 14;23(1):393. doi: 10.1186/s12876-023-03043-4.
10
Inflammation, Autoinflammation and Autoimmunity in Inflammatory Bowel Diseases.炎症性肠病中的炎症、自身炎症和自身免疫
Curr Issues Mol Biol. 2023 Jun 30;45(7):5534-5557. doi: 10.3390/cimb45070350.
抗整合素治疗炎症性肠病。
World J Gastroenterol. 2018 May 7;24(17):1868-1880. doi: 10.3748/wjg.v24.i17.1868.
4
DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome.肠上皮细胞中 DNA 甲基化和转录模式在儿童炎症性肠病患者中区分疾病亚型并与结局相关。
Gastroenterology. 2018 Feb;154(3):585-598. doi: 10.1053/j.gastro.2017.10.007. Epub 2017 Oct 12.
5
Fine-mapping inflammatory bowel disease loci to single-variant resolution.将炎症性肠病基因座精细定位到单变体分辨率。
Nature. 2017 Jul 13;547(7662):173-178. doi: 10.1038/nature22969. Epub 2017 Jun 28.
6
Pseudopolyps in inflammatory bowel diseases: Have we learned enough?炎症性肠病中的假息肉:我们了解得够多了吗?
World J Gastroenterol. 2017 Mar 7;23(9):1541-1551. doi: 10.3748/wjg.v23.i9.1541.
7
Measurement of Fibrosis in Crohn's Disease Strictures with Imaging and Blood Biomarkers to Inform Clinical Decisions.利用影像学和血液生物标志物测量克罗恩病狭窄中的纤维化以指导临床决策。
Dig Dis. 2017;35(1-2):32-37. doi: 10.1159/000449080. Epub 2017 Feb 1.
8
Leukocyte Anti-Trafficking Strategies: Current Status and Future Directions.白细胞抗迁移策略:现状与未来方向
Dig Dis. 2017;35(1-2):13-20. doi: 10.1159/000449077. Epub 2017 Feb 1.
9
Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7.通过全基因组测序探索炎症性肠病的遗传结构,发现ADCY7存在关联。
Nat Genet. 2017 Feb;49(2):186-192. doi: 10.1038/ng.3761. Epub 2017 Jan 9.
10
Crohn's disease.克罗恩病。
Lancet. 2017 Apr 29;389(10080):1741-1755. doi: 10.1016/S0140-6736(16)31711-1. Epub 2016 Dec 1.